Bug bidders to bite? Sanofi give-back opens door to replacement partner for Kalobios
Kalobios Pharmaceuticals Inc. asked for and got back the rights to KB001-A from Sanofi Pasteur, under terms that at least one analyst deemed "attractive" – especially given that the pharma partner was hardly moving the antibody along at a brisk pace.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST